Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2dc811190887931ee890a0195ab81b76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3aaac85790cabba3402cba8e62fe3557 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ce8ef25adb7e9aa36ef98fb6d97c673f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d2e675efad3d19c9deba9d014f532446 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59527f4e8053685ec62c498c0147bafa http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f323d9807f83ebb8652d5869ecbd01e3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ece2605d8510aaa2815b32daeccc12d4 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2299-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0071 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-26 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06G7-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N31-00 |
filingDate |
2011-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2013-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_759ce2a4ce58ffc2f31a8d784b8f6724 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee7481f8b63f18dc59b65ebcb8b11634 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd68a4a1148246fd78481d3ac96e1bbd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8348d9bb592495ff9b7880bdd9d44cbd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46f216297ffe8d021733bca305c247dd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8c9f0b4264e4b121c73acc57041e9ed |
publicationDate |
2013-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8512972-B2 |
titleOfInvention |
Crystal of hypoxia inducible factor 1 alpha prolyl hydroxylase |
abstract |
The crystal structure of ligand-bound EGLN1 catalytic domain of prolyl hydroxylase is disclosed. These coordinates are useful in computer aided drug design for identifying compounds that regulate EGLN1 prolyl hydroxylase and thereby regulate HIF-regulated disorders. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10596158-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10738010-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9701636-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10246416-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11065237-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11713298-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11690836-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9987262-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10149842-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10150734-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11426393-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11324734-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11267785-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11524939-B2 |
priorityDate |
2006-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |